Study for every other day administration of vonoprazan in maintenance treatment of erosive GERD: study protocol for a multicentre randomised cross-over study

INTRODUCTION: The first drug selected for treatment of gastro-oesophageal reflux disease (GERD) and prevention of the recurrence is a proton pump inhibitor (PPI), but recently, a potassium-competitive acid blocker (P-CAB) was put on the market in Japan. Its onset of effect is faster than PPI, and it...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Mototsugu, Ito, Noriko, Demura, Mamiko, Kubo, Kimitoshi, Mabe, Katsuhiro, Harada, Naohiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Gastro-Oesophageal Reflux
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841500/
https://www.ncbi.nlm.nih.gov/pubmed/29527318
http://dx.doi.org/10.1136/bmjgast-2017-000197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841500/
https://www.ncbi.nlm.nih.gov/pubmed/29527318
http://dx.doi.org/10.1136/bmjgast-2017-000197

Ejemplares similares